GNH USA

Europe — EMA

Mometasone Furoate/Olopatadine Glenmark (Mometasone Furoate, Olopatadine)

GNH USA supplies Mometasone Furoate/Olopatadine Glenmark (Mometasone furoate, Olopatadine), a corticosteroid/antihistamine nasal spray for allergic rhinitis.

Mometasone Furoate, Olopatadine

Request sourcing

1
Pack/s

What is Mometasone Furoate, Olopatadine?

Mometasone furoate and olopatadine, the active ingredients in Mometasone Furoate/Olopatadine Glenmark, are a corticosteroid/antihistamine combination presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal and perennial forms, by reducing nasal inflammation and congestion.

GNH USA supplies Mometasone Furoate/Olopatadine Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Mometasone Furoate, Olopatadine used for?

Mometasone furoate/olopatadine is used to manage allergic rhinitis and related nasal inflammation. - Seasonal allergic rhinitis: relieves sneezing, itching, rhinorrhea and nasal blockage caused by seasonal allergens. - Perennial allergic rhinitis: controls chronic nasal symptoms triggered by year‑round allergens. - Nasal congestion due to allergic inflammation: improves airflow and reduces swelling of nasal passages.

What are the side effects of Mometasone Furoate, Olopatadine?

Adverse reactions may occur with intranasal use of this corticosteroid/antihistamine combination.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Altered taste or bitter taste - Epistaxis (nosebleed) - Throat irritation - Cough

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use - Anaphylactic or severe allergic reaction - Vision changes or increased intraocular pressure - Nasal septum perforation - Opportunistic fungal infection of the nasal cavity - Severe local infection or ulceration

What precautions apply to Mometasone Furoate, Olopatadine?

Before using this nasal spray, consider the following safety measures. - Pregnancy: consult a healthcare professional; data are limited. - Breastfeeding: discuss potential risks with a clinician. - Existing nasal infections: treat infection before initiating therapy. - Concurrent systemic steroids: monitor for additive corticosteroid effects. - Children under 12 years: use only if prescribed by a qualified practitioner. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

What does Mometasone Furoate, Olopatadine interact with?

Mometasone furoate/olopatadine may interact with other medicines; awareness helps avoid complications.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic corticosteroid exposure. - Systemic corticosteroids: risk of additive glucocorticoid effects. - Live vaccines: potential reduced vaccine efficacy.

Moderate Interactions (Monitor Closely): - Other intranasal decongestants or antihistamines: may increase local irritation. - Immunosuppressants: monitor for infection risk. - Antifungal agents used nasally: assess for overlapping side‑effects.

Frequently asked questions

What is Mometasone Furoate/Olopatadine Glenmark used for?+
Mometasone Furoate/Olopatadine Glenmark is indicated for the treatment of allergic rhinitis, both seasonal and perennial, and for relieving nasal congestion caused by allergic inflammation. It combines a corticosteroid and an antihistamine to address inflammation and histamine‑mediated symptoms in the nasal passages.
How does Mometasone furoate work in this product?+
Mometasone furoate binds to glucocorticoid receptors in nasal mucosal cells, leading to reduced production of inflammatory cytokines and decreased infiltration of inflammatory cells. This anti‑inflammatory action helps to shrink swollen nasal tissue and lower mucus production.
What is the usual dose of Mometasone Furoate/Olopatadine?+
The specific dosing regimen for Mometasone Furoate/Olopatadine is determined by the prescribing clinician based on the patient’s age, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions and the product label.
Is Mometasone Furoate/Olopatadine safe during pregnancy or breastfeeding?+
Safety data for use during pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing this medication to pregnant or nursing individuals.
How do I order Mometasone Furoate/Olopatadine from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does this combination compare with other allergic rhinitis treatments?+
Compared with single‑agent antihistamine sprays, the Mometasone Furoate/Olopatadine combo offers both anti‑inflammatory and antihistaminic effects, potentially providing more comprehensive symptom control. Unlike oral antihistamines, the nasal route delivers medication directly to the site of inflammation, reducing systemic exposure.
What are the storage and handling requirements for this nasal spray?+
Store the nasal spray at ambient temperature, preferably below 25 °C. Keep the device in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.
How is Mometasone Furoate/Olopatadine administered?+
The product is administered as a nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of sprays while breathing in gently. The procedure is repeated in the other nostril if directed by the prescriber.
What are the most serious risks associated with this medication?+
Serious risks, though rare, include adrenal suppression with prolonged high‑dose use, severe allergic reactions such as anaphylaxis, nasal septum perforation, and opportunistic fungal infections of the nasal cavity. Patients should seek immediate medical attention if they experience symptoms like severe nosebleeds, vision changes, or signs of systemic infection.
Who should not use Mometasone Furoate/Olopatadine?+
Individuals with known hypersensitivity to mometasone furoate, olopatadine, or any component of the formulation should avoid this product. It is also contraindicated in patients with active untreated nasal infections or recent nasal surgery unless specifically advised by a healthcare professional.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mometasone Furoate, Olopatadine
Route
Nasal Use
Manufacturer
Glenmark Arzneimittel Gmbh
Origin
EU

Related products

Rineffix

Rineffix

Mometasone Furoate, Olopatadine

Glenmark Arzneimittel Gmbh
EU
Ryaltris

Ryaltris

Mometasone Furoate, Olopatadine

Glenmark Pharmaceuticals S.R.O.
EU
Ryaltris

Ryaltris

Mometasone Furoate, Olopatadine

Glenmark Pharmaceuticals S.R.O.
EU
Ryaltris

Ryaltris

Mometasone Furoate, Olopatadine

Glenmark Pharmaceuticals S.R.O.
EU